Table 3.
Relationship between most important attribute and unlabelled test preference
|
Attribute |
Overall (n = 911) |
US (n = 456) |
AUS (n = 455) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Unlabelled test preference |
Unlabelled test preference |
Unlabelled test preference |
||||||||||
|
No screening like option (n = 613) |
Screening-like option (n = 298) |
No screening like option (n = 336) |
Screening-like option (n = 120) |
No screening-like option (n = 277) |
Screening-like option (n = 178) |
|||||||
| N | % | N | % | N | % | N | % | N | % | N | % | |
| Chance of being diagnosed over 10 years |
172 |
28.1% |
99 |
33.2% |
92 |
27.4% |
32 |
26.7% |
80 |
28.9% |
67 |
37.6% |
| Chance of dying over 10 years |
231 |
37.7% |
140 |
47.0% |
120 |
35.7% |
61 |
50.8% |
111 |
40.1% |
79 |
44.4% |
| Chance of needing a biopsy from screening over 10 years |
73 |
11.9% |
29 |
9.7% |
43 |
12.8% |
11 |
9.2% |
30 |
10.8% |
18 |
10.1% |
| Chance of impotence/incontinence over 10 years | 137 | 22.3% | 30 | 10.1% | 81 | 24.1% | 16 | 13.3% | 56 | 20.2% | 14 | 7.9% |